Brief: Tot Biopharm International Says Unit Received Gmp Compliance Inspection Report
25/10/2022 15:53
Oct 25 (Reuters) - TOT BIOPHARM International 1875.HK :
* UNIT RECEIVED A GMP COMPLIANCE INSPECTION REPORT APPROVED
BY A
QUALIFIED PERSON IN EUROPEAN UNION
* COMPLIANCE REPORT FOR MANUFACTURING FACILITIES OF
COMMERCIAL
PRODUCTION BASE FOR CANDIDATE, TAA013
Further company coverage: 1875.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioDlink International
See all newsCorrected: China's BioDlink International HY revenue falls (September 29)
Brief: Biodlink International To Deliver Ten Batches Of Monoclonal Antibody Intermediates To Wuxi Biologics
Brief: Biodlink International Says Shan Fu Resigns As Executive Director And Chairperson
Brief: BioDlink International Says WuXi XDC Cayman To Make Conditional Cash Offer For All Co Shares
Brief: HKEX Says Trading In Shares Of Biodlink International Will Be Halted At Dec 29